Notice: This company has been marked as potentially delisted and may not be actively trading. Angion Biomedica (ANGN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Akari Therapeutics PLC ADRSeptember 19, 2024 | wsj.comOXBDF Oxford Biomedica plcJuly 31, 2024 | seekingalpha.comAngion Biomedia Corp. Announces 1-for-10 Reverse Stock SplitJune 1, 2023 | finance.yahoo.com8-K: Angion Biomedica Corp.May 2, 2023 | marketwatch.comCompanies Like Angion Biomedica (NASDAQ:ANGN) Could Be Quite RiskyApril 27, 2023 | finance.yahoo.comSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVAApril 11, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, ANGN, TIGApril 6, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLI, DCT, ANGNMarch 4, 2023 | stockhouse.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, OSH, IAAFebruary 24, 2023 | stockhouse.comMoore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law FirmJanuary 22, 2023 | benzinga.comSTOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Angion Biomedica Corp. - ANGNJanuary 18, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Angion Biomedica Corp. MergerJanuary 17, 2023 | benzinga.comAngion Biomedica Shares Tumble Premarket on Elicio Tie-Up >ANGNJanuary 17, 2023 | marketwatch.comANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to ShareholdersJanuary 17, 2023 | technews.tmcnet.comBullish insiders bet US$857k on Angion Biomedica Corp. (NASDAQ:ANGN)December 27, 2022 | finance.yahoo.comAngion Biomedica Corp.: Angion Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsDecember 22, 2022 | finanznachrichten.deAngion Receives Nasdaq Notice Regarding Minimum Bid Price RequirementsDecember 22, 2022 | finance.yahoo.comNabriva (NBRV) Posts Positive Data From Cystic Fibrosis StudyNovember 29, 2022 | nasdaq.comAxsome (AXSM) Gains as Alzheimer's Agitation Study Meets GoalNovember 29, 2022 | nasdaq.comReasons to Add Immunovant (IMVT) Stock to Your Portfolio NowNovember 24, 2022 | msn.comImmunovant (IMVT) Rises More Than 150% in 3 Months: Here's HowNovember 17, 2022 | nasdaq.comJazz's (JAZZ) Q3 Earnings Beat Estimates, New Drugs Drive SalesNovember 10, 2022 | finance.yahoo.comKaruna Therapeutics (KRTX) Posts Wider-Than-Expected Q3 LossNovember 4, 2022 | finance.yahoo.comLilly (LLY) Beats on Q3 Earnings & Sales, Lowers '22 ViewNovember 1, 2022 | finance.yahoo.comIs Angion Biomedica (NASDAQ:ANGN) In A Good Position To Deliver On Growth Plans?October 13, 2022 | finance.yahoo.comAngion Biomedica Corp. (ANGN)September 24, 2022 | finance.yahoo.comAngion Biomedica's Return On Capital Employed OverviewSeptember 12, 2022 | msn.comAngion Biomedica Corp Ordinary SharesSeptember 9, 2022 | morningstar.comRecap: Angion Biomedica Q2 EarningsAugust 17, 2022 | benzinga.comAngion Provides Corporate Update and Reports Second Quarter 2022 Financial ResultsAugust 15, 2022 | finance.yahoo.comAngion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder ValueJuly 25, 2022 | finance.yahoo.comTrading was temporarily halted for "ANGN" at 04:07 PM with a stated reason of "News pending."July 25, 2022 | marketbeat.comHC Wainwright Downgrades Angion BiomedicaJuly 18, 2022 | finance.yahoo.comAngion Biomedica Corp Ordinary Shares - Stock Quote ANGNJuly 1, 2022 | morningstar.comAngion Biomedica Shares Plumb New Depths After Study Setback >ANGNJuly 1, 2022 | marketwatch.comAngion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read WhyJune 30, 2022 | finance.yahoo.comAngion Biomedica shares dive after kidney-disease drug trial discontinuedJune 29, 2022 | finance.yahoo.comAngion Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney DiseaseJune 29, 2022 | finance.yahoo.comAngion to discontinue phase 2 trial of ANG-3070 in patients with kidney diseaseJune 29, 2022 | seekingalpha.comTrading was temporarily halted for "ANGN" at 04:06 PM with a stated reason of "News pending."June 29, 2022 | marketbeat.comJay Venkatesan Is The President of Angion Biomedica Corp. (NASDAQ:ANGN) And They Just Picked Up 5.7% More SharesMay 28, 2022 | finance.yahoo.comAngion Provides Corporate Update and Reports First Quarter 2022 Financial ResultsMay 16, 2022 | finance.yahoo.comAngion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary FibrosisMay 16, 2022 | finance.yahoo.com5 Biotech Stocks Set to Outpace Q1 Earnings EstimatesMay 11, 2022 | finance.yahoo.comHere's Why We're Watching Angion Biomedica's (NASDAQ:ANGN) Cash Burn SituationMay 6, 2022 | finance.yahoo.comAngion Announces Participation in Upcoming Investment ConferenceApril 14, 2022 | finance.yahoo.comAngion Biomedica GAAP EPS of -$1.93, revenue of $28.31MApril 1, 2022 | seekingalpha.comAngion Provides Corporate Update and Reports Full Year 2021 Financial ResultsMarch 30, 2022 | finance.yahoo.comPrecision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue EstimatesMarch 15, 2022 | msn.comEvogene (EVGN) Reports Q4 Loss, Tops Revenue EstimatesMarch 10, 2022 | nasdaq.com Get Angion Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGN and its competitors with MarketBeat's FREE daily newsletter. Email Address ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> ANGN Media Mentions By Week ANGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGN News Sentiment▼0.000.59▲Average Medical News Sentiment ANGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGN Articles This Week▼00▲ANGN Articles Average Week Get Angion Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LianBio News Today PHAXIAM Therapeutics News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Angion Biomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Angion Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
